In today’s recent session, 0.76 million shares of the Astera Labs Inc (NASDAQ:ALAB) have been traded, and its beta is -0.36. Most recently the company’s share price was $73.07, and it changed around $1.97 or 2.77% from the last close, which brings the market valuation of the company to $11.85B. ALAB at last check was trading at a discount to its 52-week high of $147.39, offering almost -101.71% off that amount. The share price’s 52-week low was $36.22, which indicates that the recent value has risen by an impressive 50.43% since then. We note from Astera Labs Inc’s average daily trading volume that its 10-day average is 3.71 million shares, with the 3-month average coming to 5.11 million.
Astera Labs Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 15 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 1 recommended ALAB as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Astera Labs Inc is expected to report earnings per share of 0.28 for the current quarter.
Astera Labs Inc (NASDAQ:ALAB) trade information
Instantly ALAB has been showing a green trend so far today with a performance of 2.77% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 74.80 on recent trading dayincreased the stock’s daily price by 2.31%. The company’s shares are currently down -44.83% year-to-date, but still up 1.42% over the last five days. On the other hand, Astera Labs Inc (NASDAQ:ALAB) is -14.75% down in the 30-day period. We can see from the shorts that 9.55 million shares have been sold at a short interest cover period of 1.53 day(s).
The consensus price target as assigned by Wall Street analysts is $100, which translates to bulls needing to increase their stock price by 26.93% from its current value. Analyst projections state that ALAB is forecast to be at a low of $74 and a high of $110.
Astera Labs Inc (ALAB) estimates and forecasts
The year-over-year growth rate is expected to be 70.39%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 151.55M in revenue for the current quarter. 10 analysts expect Astera Labs Inc to make 159.53M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 65.26M and 76.85M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 132.23%. Forecasts for the next quarter put sales growth at 107.58%.
Astera Labs Inc earnings are expected to increase by 50.07% in 2025, but the outlook is positive 43.48% per year for the next five years.
Astera Labs Inc (NASDAQ:ALAB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 15.86% of Astera Labs Inc shares, and 69.18% of them are in the hands of institutional investors. The stock currently has a share float of 82.23%. Astera Labs Inc stock is held by 519.0 institutions, with INTEL CORP being the largest institutional investor. By 2024-06-30, it held 3.8036% of the shares, which is about 5.9 million shares worth $357.21 million.
ATREIDES MANAGEMENT, LP, with 1.7889% or 2.78 million shares worth $168.0 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Fidelity Growth Company Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 3.73 shares worth $273.09 million, making up 2.30% of all outstanding shares. On the other hand, Fidelity Growth Company Fund held roughly 3.35 shares worth around $244.99 million, which represents about 2.06% of the total shares outstanding.
